Corporate Law Individual Research Essay Outline

CORPORATE LAW (BO1CLAW314)
INDIVIDUAL RESEARCH ESSAY: OUTLINE
DUE DATE: Night before your CLAW class in WK7
(see example at the end)
ESSAY OUTLINE
Q 1: My understanding of the essay question is: whether any statutory as
well as equitable remedies are available to Tim considering the facts and
circumstances of the case.
_____________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
Tip s fo r ans we ring Q1 :
 B re ak the que sti on dow n i nto smal l e r parts
 Expl ai n to me , usi ng pl ai n Engl i sh, w hat the que sti on me ans/ i s aski ng
 O nl y focus on the que sti on... pl e ase do NO T start expl ai ni ng your e ssay ye t
Q 2: The primary authorities (Case Law/ Legislation) I plan to refer to in my
essay are:
 The Corporations Act 2001
 The Common Law ___________________________________
 Foss v Harbottle (1843) 67 ER 189____________________________________

Short v Crawley (No 30) [2007] NSWSC 1322**
 Nicholls v Michael Wilson & Partners Ltd [2012] NSWCA 383**
 ____________________________________
Re se arch : Pl e ase i ndi cate (**) w hi ch tw o (2 ) authori ti e s w e re NO T found i n
your te xtbook
Q 3: The secondary sources (books, articles, websites etc) I plan to refer to
in my essay are:
 Vivien, C.H.E.N., 2017. The Statutory Derivative Action in Malaysia:
Comparison with an Australian Judicial Approach.
Asian Journal of
Comparative Law,
12(2).
 ____________________________________
CREATED: March 2019 Kent Institute Australia
ABN 49 003 577 302
CRICOSCode: 00161E National Code: 90458
TEQSA Provider Number: PRV12051
STUDENT DETAILS: ________________________________________________________________________

 ____________________________________
 Tang, S.S., 2016. Corporate avengers need not be angels: rethinking
good faith in the derivative action.
Journal of Corporate Law
Studies,
16(2), pp.471-491
 ____________________________________
____________________
 ____________________________________
Q 4: Outline of your argument:
“In my essay I plan to argue that: from the facts of the case, it is seen that
Tim was subjected to oppression and unfair discrimination by his brothers
because of their majority votes. Tim being the minority shareholder cannot
oppose them. Hence he has claim remedies as per the provisions of the
Corporations Act 2001 and the principle of equity.
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________”
“I will come to the conclusion that: Tim though being a minority
shareholder can prevent oppression against him by claiming suitable
remedies under the provisions of statutory law and
equity._______________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________________________________________________________________“
(END)
Tips f o r ans we ring Q4 :
 Thi nk of i t thi s w ay: If I w as to ask you to e xpl ai n your e nti re l i ne of
argume nt to me i n unde r 10 se conds, w hat w oul d you say?
CREATED: March 2019 Kent Institute Australia
ABN 49 003 577 302
CRICOSCode: 00161E National Code: 90458
TEQSA Provider Number: PRV12051